You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Apixaban for preventing venous thromboembolism after hip or knee replacement surgery

  • Technology appraisal guidance
  • Reference number: TA245
  • Published:  25 January 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Appraisal Committee members, guideline representatives and NICE project team
  • 8 Sources of evidence considered by the Committee
  • 9 Update information

1 Recommendations

1.1

Apixaban is recommended, within its marketing authorisation, as an option for preventing venous thromboembolism in adults after elective hip or knee replacement surgery.


Next page 2 The technology Previous page Overview
Back to top